Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Genomic Testing – The Key to Knowing Your Cancer

Just as every patient is unique, so is every tumor. And when your doctor orders genomic testing, they’re actually searching for the specific key to unlocking which treatment approach may be most appropriate for you.

Unlike a genetic test, which assesses your hereditary risk for cancer, a genomic test looks at your cancer tissue to provide information on how your specific tumor might behave. It identifies changes in DNA that may be driving the growth of your tumor, as well as other vital information, such as how likely your cancer is to spread.

How genomic testing works

Step 1

In most cases, the tissue from your original biopsy is sent to our lab and no extra procedures are required.

Step 2

Test results are sent to your doctor.

Step 3

You and your doctor review the results together to choose which treatment will be most appropriate for you.

See how we can help with your specific cancer

Discover more about the genomic test that your doctor may have already ordered for you. Plus, learn what to expect from the test results, hear patient stories, watch videos, get answers to FAQs, and more.

Tests are widely accessible, with $0 to minimal out-of-pocket costs for most patients*

At Exact Sciences, we’re working hard to ensure that you have access to what you need to make confident, informed decisions about your cancer treatment.

Real Patients, Real Stories

  • Meet Deepa

    A surgeon diagnosed with node negative, invasive breast cancer who used the Oncotype DX Breast Recurrence Score test to help inform a decision to not get chemotherapy.

  • Do you know your Oncotype DX Genomic Prostate Score? Meet Jim

  • Amy's Oncotype DX Breast DCIS Score Story

    Amy, a breast cancer survivor, describes her experience using Genomic Health's Oncotype DX DCIS Breast Cancer Score to personalize her treatment options. Share this video with your loved ones to help empower other women facing a DCIS (ductal carcinoma in situ) breast cancer diagnosis to ask for personalized treatment. For more information, please visit: www.genomichealth.com www.oncotypedx.com

Share your story

Help other patients by sharing your experiences with Oncotype or Oncomap. Email us your story at patientstories@exactsciences.com to become an Exact Sciences Patient Ambassador.